These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 37515588

  • 1. Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy.
    Quaye E, Chacko S, Startzell M, Brown RJ.
    J Clin Endocrinol Metab; 2023 Dec 21; 109(1):e209-e215. PubMed ID: 37515588
    [Abstract] [Full Text] [Related]

  • 2. Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy.
    Brown RJ, Valencia A, Startzell M, Cochran E, Walter PJ, Garraffo HM, Cai H, Gharib AM, Ouwerkerk R, Courville AB, Bernstein S, Brychta RJ, Chen KY, Walter M, Auh S, Gorden P.
    J Clin Invest; 2018 Aug 01; 128(8):3504-3516. PubMed ID: 29723161
    [Abstract] [Full Text] [Related]

  • 3. Leptin Decreases Energy Expenditure Despite Increased Thyroid Hormone in Patients With Lipodystrophy.
    Grover A, Quaye E, Brychta RJ, Christensen J, Startzell MS, Meehan CA, Valencia A, Marshall B, Chen KY, Brown RJ.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4163-e4178. PubMed ID: 33890058
    [Abstract] [Full Text] [Related]

  • 4. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
    Baykal AP, Parks EJ, Shamburek R, Syed-Abdul MM, Chacko S, Cochran E, Startzell M, Gharib AM, Ouwerkerk R, Abd-Elmoniem KZ, Walter PJ, Walter M, Muniyappa R, Chung ST, Brown RJ.
    JCI Insight; 2020 Jul 23; 5(14):. PubMed ID: 32573497
    [Abstract] [Full Text] [Related]

  • 5. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    Brown RJ, Meehan CA, Cochran E, Rother KI, Kleiner DE, Walter M, Gorden P.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1511-1519. PubMed ID: 28324110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glycerol not lactate is the major net carbon source for gluconeogenesis in mice during both short and prolonged fasting.
    Wang Y, Kwon H, Su X, Wondisford FE.
    Mol Metab; 2020 Jan 01; 31():36-44. PubMed ID: 31918920
    [Abstract] [Full Text] [Related]

  • 8. Energy expenditure due to gluconeogenesis in pathological conditions of insulin resistance.
    Quaye E, Chacko S, Chung ST, Brychta RJ, Chen KY, Brown RJ.
    Am J Physiol Endocrinol Metab; 2021 Dec 01; 321(6):E795-E801. PubMed ID: 34693755
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems.
    Neese RA, Schwarz JM, Faix D, Turner S, Letscher A, Vu D, Hellerstein MK.
    J Biol Chem; 1995 Jun 16; 270(24):14452-66. PubMed ID: 7782307
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide.
    Akinci B, Meral R, Rus D, Hench R, Neidert AH, DiPaola F, Westerhoff M, Taylor SI, Oral EA.
    Endocrinol Diabetes Metab Case Rep; 2020 Mar 25; 2020():. PubMed ID: 32213649
    [Abstract] [Full Text] [Related]

  • 14. Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    Nguyen ML, Sachdev V, Burklow TR, Li W, Startzell M, Auh S, Brown RJ.
    J Clin Endocrinol Metab; 2021 Oct 21; 106(11):e4327-e4339. PubMed ID: 34223895
    [Abstract] [Full Text] [Related]

  • 15. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
    Chan JL, Lutz K, Cochran E, Huang W, Peters Y, Weyer C, Gorden P.
    Endocr Pract; 2011 Oct 21; 17(6):922-32. PubMed ID: 22068254
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, Young J, Mathivon L, Travert F, Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M, Gautier J, Vigouroux C.
    Diabetes Obes Metab; 2016 Jul 21; 18(7):693-7. PubMed ID: 26584826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New advances in the treatment of generalized lipodystrophy: role of metreleptin.
    Rodriguez AJ, Mastronardi CA, Paz-Filho GJ.
    Ther Clin Risk Manag; 2015 Jul 21; 11():1391-400. PubMed ID: 26396524
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.